vs
Side-by-side financial comparison of Bandwidth Inc. (BAND) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $208.8M, roughly 1.6× Bandwidth Inc.). HAEMONETICS CORP runs the higher net margin — 13.2% vs 1.9%, a 11.3% gap on every dollar of revenue. On growth, Bandwidth Inc. posted the faster year-over-year revenue change (20.1% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $-1.0M). Over the past eight quarters, Bandwidth Inc.'s revenue compounded faster (9.7% CAGR vs 0.4%).
Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
BAND vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.8M | $339.0M |
| Net Profit | $4.0M | $44.7M |
| Gross Margin | 37.3% | 59.7% |
| Operating Margin | 60.5% | 19.9% |
| Net Margin | 1.9% | 13.2% |
| Revenue YoY | 20.1% | -2.7% |
| Net Profit YoY | 200.0% | 19.3% |
| EPS (diluted) | $-0.08 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $208.8M | — | ||
| Q4 25 | $207.7M | $339.0M | ||
| Q3 25 | $191.9M | $327.3M | ||
| Q2 25 | $180.0M | $321.4M | ||
| Q1 25 | $174.2M | $330.6M | ||
| Q4 24 | $210.0M | $348.5M | ||
| Q3 24 | $193.9M | $345.5M | ||
| Q2 24 | $173.6M | $336.2M |
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | $44.7M | ||
| Q3 25 | $-1.2M | $38.7M | ||
| Q2 25 | $-4.9M | $34.0M | ||
| Q1 25 | $-3.7M | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $413.0K | $33.8M | ||
| Q2 24 | $4.1M | $38.4M |
| Q1 26 | 37.3% | — | ||
| Q4 25 | 37.6% | 59.7% | ||
| Q3 25 | 38.5% | 59.5% | ||
| Q2 25 | 39.8% | 59.8% | ||
| Q1 25 | 41.0% | 58.4% | ||
| Q4 24 | 36.4% | 55.5% | ||
| Q3 24 | 37.7% | 54.2% | ||
| Q2 24 | 37.3% | 52.0% |
| Q1 26 | 60.5% | — | ||
| Q4 25 | -1.9% | 19.9% | ||
| Q3 25 | -1.0% | 17.9% | ||
| Q2 25 | -2.1% | 16.8% | ||
| Q1 25 | -2.7% | 21.6% | ||
| Q4 24 | -1.3% | 16.9% | ||
| Q3 24 | -0.5% | 15.0% | ||
| Q2 24 | -3.5% | 11.8% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | 13.2% | ||
| Q3 25 | -0.6% | 11.8% | ||
| Q2 25 | -2.7% | 10.6% | ||
| Q1 25 | -2.1% | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | 0.2% | 9.8% | ||
| Q2 24 | 2.3% | 11.4% |
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $-0.10 | $0.95 | ||
| Q3 25 | $-0.04 | $0.81 | ||
| Q2 25 | $-0.16 | $0.70 | ||
| Q1 25 | $-0.13 | $1.17 | ||
| Q4 24 | $0.27 | $0.74 | ||
| Q3 24 | $0.01 | $0.66 | ||
| Q2 24 | $-0.17 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $405.7M | $911.5M |
| Total Assets | $984.2M | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $111.3M | $363.4M | ||
| Q3 25 | $80.4M | $296.4M | ||
| Q2 25 | $68.1M | $292.9M | ||
| Q1 25 | $41.7M | $306.8M | ||
| Q4 24 | $83.8M | $320.8M | ||
| Q3 24 | $79.9M | $299.3M | ||
| Q2 24 | $76.4M | $344.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $405.7M | — | ||
| Q4 25 | $400.0M | $911.5M | ||
| Q3 25 | $392.7M | $849.2M | ||
| Q2 25 | $384.5M | $882.3M | ||
| Q1 25 | $345.4M | $820.8M | ||
| Q4 24 | $312.5M | $906.9M | ||
| Q3 24 | $336.6M | $878.9M | ||
| Q2 24 | $307.4M | $905.4M |
| Q1 26 | $984.2M | — | ||
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.0B | $2.4B | ||
| Q2 25 | $1.0B | $2.5B | ||
| Q1 25 | $964.4M | $2.5B | ||
| Q4 24 | $989.2M | $2.5B | ||
| Q3 24 | $1.0B | $2.5B | ||
| Q2 24 | $1.0B | $2.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $93.6M |
| Free Cash FlowOCF − Capex | $-1.0M | $87.2M |
| FCF MarginFCF / Revenue | -0.5% | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $38.6M | $93.6M | ||
| Q3 25 | $22.2M | $111.3M | ||
| Q2 25 | $31.7M | $17.4M | ||
| Q1 25 | $-3.1M | $116.6M | ||
| Q4 24 | $36.5M | $43.8M | ||
| Q3 24 | $20.5M | $48.8M | ||
| Q2 24 | $24.4M | $-27.4M |
| Q1 26 | $-1.0M | — | ||
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M |
| Q1 26 | -0.5% | — | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | 49.55× | 1.44× | ||
| Q2 24 | 6.03× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BAND
Segment breakdown not available.
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
